Precision
Peptides.

A 29-amino acid analogue of endogenous Growth Hormone-Releasing Hormone (GHRH). Sermorelin acts directly on pituitary somatotroph cells to stimulate the pulsatile release of growth hormone. Widely studied for its role in GH secretion dynamics and somatotropic axis research.

A selective, third-generation growth hormone secretagogue (GHS) and ghrelin receptor agonist. Ipamorelin demonstrates high GH selectivity with minimal effect on cortisol, prolactin, or ACTH levels — making it a precise research tool for isolated GH axis studies.

A long-acting synthetic analogue of GHRH incorporating Drug Affinity Complex (DAC) technology. The DAC modification enables covalent binding to serum albumin, dramatically extending biological half-life to 6–8 days. Critical research tool for studying sustained GH axis stimulation.

A synthetic hexapeptide and second-generation growth hormone secretagogue. GHRP-2 acts on both ghrelin receptors in the hypothalamus and pituitary, producing robust GH pulses. Frequently co-administered with GHRH analogues in research to amplify GH release.

One of the original synthetic growth hormone secretagogues, GHRP-6 is a hexapeptide that potently stimulates GH release via ghrelin receptor activation. Distinguished by its notable effect on appetite and gastric motility, offering a unique research profile compared to newer GHSs.

A stabilized analogue of the C-terminal region (residues 176-191) of human growth hormone. Research indicates this fragment retains the lipolytic activity of full-length HGH without binding to GH receptors or influencing IGF-1 levels — making it an ideal isolated research model.

Body Protection Compound-157 is a synthetic pentadecapeptide derived from a protective gastric protein. Extensively studied for its effects on angiogenesis, tendon and ligament healing, gut barrier integrity, and neuroprotection. One of the most researched regenerative peptides available.

A synthetic analogue of the naturally occurring Thymosin Beta-4 protein. TB-500 is a 43-amino acid peptide that promotes actin upregulation, cell migration, and tissue remodeling. Extensively researched in models of wound healing, cardiac repair, and neural regeneration.

A naturally occurring copper complex of the tripeptide Gly-His-Lys. GHK-Cu exhibits pleiotropic biological activity in research including collagen synthesis stimulation, antioxidant effects, anti-inflammatory modulation, and nerve growth factor (NGF) production — a key compound in tissue biology research.

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) and analogue of the natural pineal gland peptide Epithalamin. Research has focused on its effects on telomerase activation, telomere elongation, circadian rhythm regulation, and neuroendocrine axis modulation. A subject of significant longevity research.

An analogue of amino acids 177-191 of the C-terminus of human growth hormone, with an additional Tyr residue at the N-terminus. AOD-9604 has been studied for its selective lipolytic and anti-lipogenic properties without measurable effects on IGF-1 or blood glucose — distinguishing it as a metabolic research compound.

A synthetic analogue of GHRH with a trans-3-hexenoic acid group conjugated to the N-terminus, improving stability against DPP-IV degradation. Tesamorelin has been extensively studied for visceral adiposity reduction and GH axis stimulation with a favorable safety profile compared to direct GH administration.

A cyclic heptapeptide derived from Melanotan II and a melanocortin receptor agonist. PT-141 acts centrally via MC3R and MC4R pathways rather than through the vascular system, making it a unique research tool for studying central mechanisms of arousal, motivation, and melanocortin signalling.

A cyclic lactam analogue of alpha-melanocyte-stimulating hormone (α-MSH). Melanotan II is a non-selective melanocortin receptor agonist studied for its effects on pigmentation, energy homeostasis, and reproductive biology. A foundational compound in melanocortin receptor pharmacology research.

A synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin. Selank exhibits anxiolytic properties in animal models via serotonergic and dopaminergic pathways, with additional research demonstrating memory enhancement and BDNF upregulation without sedation or dependence.

A synthetic heptapeptide derived from the N-terminal fragment of ACTH(4-10) with a Pro-Gly-Pro C-terminal extension conferring resistance to enzymatic degradation. Research has documented BDNF and NGF upregulation, improved cognitive performance metrics, and neuroprotective effects in ischemia models.